Behandlingsmuligheder ved kronisk norovirusinfektion hos immunkompromitterede patienter

Translated title of the contribution: Treatment options for chronic norovirus infection in immunocompromised patients

Ann-Camilla Worsøe Christensen, Camilla Heldbjerg Drabe, Anne-Mette Lebech, Terese L Katzenstein*

*Corresponding author for this work

Abstract

Norovirus is generally an acute infection causing symptoms such as diarrhea, nausea, and vomiting lasting for 24-48 hours. However, for immunocompromised patients, norovirus gastroenteritis can last for several years and result in villous atrophy and lead to severe malnutrition, dehydration, electrolyte imbalance and continuous viral shedding. Several treatment strategies have been suggested in case reports: nitazoxanide, ribavirin and enterally administered immunoglobulin with varying results. Favipiravir is also suggested but not tested on humans, highlighting the need for further research.

Translated title of the contributionTreatment options for chronic norovirus infection in immunocompromised patients
Original languageDanish
Article numberV10220659
JournalUgeskrift for Laeger
Volume185
Issue number12
ISSN0041-5782
Publication statusPublished - 20 Mar 2023

Fingerprint

Dive into the research topics of 'Treatment options for chronic norovirus infection in immunocompromised patients'. Together they form a unique fingerprint.

Cite this